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PDiabetes and Detection of CAD
dentifying High-Risk Asymptomatic Diabetic
atients Who Are Candidates for Screening Stress
ingle-Photon Emission Computed Tomography Imaging
avin Rajagopalan, MD,* Todd D. Miller, MD, FACC,* David O. Hodge, MS,†
obert L. Frye, MD, FACC,* Raymond J. Gibbons, MD, FACC*
ochester, Minnesota
OBJECTIVES The purpose of this study was to identify which asymptomatic diabetic patients are candidates for
screening single-photon emission computed tomography (SPECT) imaging and to examine
angiographic findings and mortality in patients according to SPECT imaging categories.
BACKGROUND Previously we reported a high percentage of abnormal and high-risk SPECT imaging scans
in asymptomatic diabetic patients.
METHODS We examined the associations between several clinical and laboratory variables and a high-risk
stress SPECT imaging scan in 1,427 asymptomatic diabetic patients without known coronary
artery disease (CAD). Results of coronary angiography and long-term outcome were also
analyzed.
RESULTS An abnormal stress SPECT imaging scan was present in 826 patients (58%) and a high-risk
scan in 261 patients (18%). Multivariate analysis demonstrated that seven variables were
independently associated with a high-risk scan (model chi-square  107, p  0.0001). The
two most important variables were electrocardiogram (ECG) Q waves (adjusted chi-square
38.3, p  0.001) and peripheral arterial disease (PAD) (adjusted chi-square  13.9, p 
0.001). Coronary angiography was performed in 127 (49%) high-risk SPECT imaging
patients, 61% of whom had angiographic high-risk CAD. Annual mortality rates for patient
subsets categorized by SPECT imaging scans were high-risk 5.9%, intermediate-risk 5.0%,
and low-risk 3.6% (p  0.001 for differences between groups).
CONCLUSIONS High-risk findings on stress SPECT imaging were present in 18% of asymptomatic diabetic
patients without known CAD. Patients with high-risk scans had a high prevalence of severe
CAD and a high annual mortality rate. ECG Q waves and/or evidence of PAD identified the
most suitable candidates for screening. (J Am Coll Cardiol 2005;45:43–9) © 2005 by the
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.06.078American College of Cardiology Foundation
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ppproximately 75% of diabetic patients die of coronary artery
isease (CAD) (1). Coronary artery disease is more likely to be
ilent in diabetic patients (2,3). American Diabetes Association
uidelines recommend screening for CAD in asymptomatic
iabetic patients who have an abnormal resting electrocardio-
ram (ECG) indicative of myocardial infarction (MI) or
schemia, peripheral arterial disease (PAD), or two or more
dditional CAD risk factors (4). These recommendations are
he result of expert opinion and are not evidence-based. Stress
ingle-photon emission computed tomography (SPECT) im-
ging is accurate for diagnostic and prognostic purposes in
eneral and in diabetic populations (5–9). In a previous study
e compared the yield of stress SPECT imaging in asymp-
omatic and symptomatic diabetic and nondiabetic patients
10). An abnormal SPECT imaging scan was present in 59%
f asymptomatic diabetic patients, including 20% with a
high-risk” scan. The purpose of this study was to define the
oronary anatomy and prognosis of asymptomatic diabetic
atients with a high-risk scan and to identify a subset of
From the Departments of *Internal Medicine and Cardiovascular Diseases and
Biostatistics, Mayo Foundation, Rochester, Minnesota.w
Manuscript received September 12, 2003; revised manuscript received May 14,
004, accepted June 23, 2004.symptomatic diabetic patients who would benefit most from
creening SPECT imaging.
ETHODS
atient population. The study was approved by the Mayo
linic Institutional Review Board. The nuclear cardiology
atabase was used to identify the study population (10).
etween January 1986 and December 2000, 67,828 stress
PECT imaging studies were performed. The following
xclusion criteria were applied: 1) clinical history of docu-
ented MI (n  19,511); 2) prior percutaneous coronary
rtery intervention or bypass surgery (n  22,841); 3) left
undle branch block or paced rhythm (n  4,406);
) significant valvular heart disease (n 5,679); 5) refusal to
uthorize use of medical record for research purposes as
equired by Minnesota law (n  77); and 6) technically
uboptimal scan (n  2,408). These criteria were applied to
xclude patients with known CAD or with entities associ-
ted with false-positive SPECT imaging studies. For pa-
ients who underwent multiple studies (n 9,736), only the
rst study was analyzed. From this population, 1,738
atients with diabetes who were coded as asymptomatic
ere identified.
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High-Risk Asymptomatic Diabetic Patients January 4, 2005:43–9The charts of all 1,738 patients were subsequently re-
iewed to address several potential limitations of the data-
ase. The goal of the study was to identify asymptomatic
iabetic patients without present or past evidence of CAD.
ne limitation of using the database was related to coding
f symptom status only at the time of stress SPECT
maging. For instance, a patient who developed chest pain
hree months before stress testing and was started on
nti-anginal medication with resolution of symptoms would
e coded as asymptomatic. Prior performance of coronary
ngiography at the Mayo Clinic or another institution was
ot recorded in the database. Peripheral arterial disease,
hich is common in diabetic patients and is a marker of
AD (11), also was not recorded. Finally, modest changes
n the definition of diabetes occurred during the study
eriod. The charts were reviewed to eliminate patients with
revious chest symptoms or known CAD by coronary
ngiography; to ensure that all patients met the current
efinition of diabetes (fasting glucose 126 mg/dl) (12);
nd to collect information on PAD (including carotid artery
isease), type of diabetes, and indication for testing. This
eview excluded 224 patients with a past history of chest
ymptoms or CAD by angiography and 87 patients who did
ot meet the definition of diabetes. The final study group
onsisted of 1,427 patients.
Clinical variables were obtained via the nuclear laboratory
atabase and chart review. Hypertension was defined as
lood pressure 140/90 mm Hg or prior diagnosis of
ypertension. Hyperlipidemia was defined as total choles-
erol or triglycerides 90th percentile for age or use of
ipid-lowering medication. Family history of premature
AD was defined as CAD in a first-degree relative 60
ears of age. The presence of PAD was determined by
ymptoms, physical examination, and/or vascular studies.
aboratory variables were obtained by cross-linking with
he Mayo Clinic laboratory medicine database. Variables
losest in time to the selected patient’s stress study were
hosen. Lipid values were available in 1,315 patients (92%),
reatinine in 1,396 patients (98%), and glycosylated hemo-
lobin in 1,314 patients (92%).
tress SPECT imaging. These methods have been de-
cribed previously (13,14). Stress protocols employed tread-
Abbreviations and Acronyms
CAD  coronary artery disease
CI  confidence interval
DIAD  Detection of Ischemia in Asymptomatic
Diabetics
ECG  electrocardiogram
LDL  low-density lipoprotein
MI  myocardial infarction
PAD  peripheral arterial disease
SPECT  single-photon emission computed tomography
SRS  summed rest score
SSS  summed stress scoreill exercise (n  739), intravenous adenosine 140 g/kg/ Tin for 6 min or dipyridamole 0.56 mg/kg over 4 min (n 
88), or intravenous dobutamine in 10 g/kg/min incre-
ents every 3 min to a peak dose of 40 to 60 g/kg/min
n  51).
Thallium-201 SPECT imaging was performed using a
ne-day protocol. Three to four mCi of thallium-201 were
njected during stress. Five to 10 min later, an anterior
lanar image was acquired for 5 min for assessment of
ardiac size and pulmonary uptake, followed by tomo-
raphic imaging over a 180° arc using the “step-and-shoot”
ethod. Delayed images were acquired three to four hours
ater. After January 1, 1990, patients were re-injected with
mCi of thallium-201. Technetium-99m sestamibi
PECT imaging was performed as a 1-day (8 to 10 mCi
est, 22 to 24 mCi stress) or 2-day (30 mCi rest, 15 mCi
tress) protocol. Tomographic imaging was started 45 to 60
in after injection of sestamibi.
Stress and rest images were displayed in 3 planes (short-
xis, horizontal long-axis, vertical long-axis) divided into
4 segments. Uptake in each segment was graded by
onsensus of two experienced observers using a five-point
cale (0  absent, 1  severely diminished, 2  moderately
iminished, 3  mildly diminished, 4  normal). Mild
xed defects were considered normal because the large
ajority represents soft tissue attenuation. Moderate or
evere fixed defects or defects with any reversibility were
onsidered abnormal. Summed stress score (SSS) and
ummed rest score (SRS) were determined as the summa-
ion of perfusion grading in all 14 short-axis segments. A
ormal image score is 56 (14  4). The SSS risk categories
ere assigned according to Cedars-Sinai criteria adapted for
ur scoring system as low-risk (SSS53), intermediate-risk
SSS 48 to 52), and high-risk (SSS 47) (15).
oronary angiography. Results of coronary angiography
erformed at the Mayo Clinic within six months were
ollected. Angiograms were interpreted subjectively by two
xperienced angiographers and graded according to Coro-
ary Artery Surgery Study criteria (luminal diameter nar-
owing 50% left main or 70% left anterior descending,
eft circumflex, right coronary artery, or their major
ranches considered significant) (16).
urvival analysis. Mortality data were obtained from
ayo Clinic records and the Social Security Death Index.
urvival was estimated using the Kaplan-Meier method.
urvival curves were compared using the log-rank statistic.
ean duration of follow-up was 5.8  3.5 years.
tatistical methods. Associations between a high-risk
PECT scan and 25 clinical and laboratory variables were
ested using logistic regression models. Multivariate mod-
ling included the bootstrap approach. One thousand boot-
trap samples were taken from the population of 1,427
atients. Multivariate models were constructed using logis-
ic regression and a stepwise selection technique for each of
hese 1,000 samples. Variables that entered at least 65% of
he models were selected for the final multivariate models.
est indication (preoperative or other) was not initially
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January 4, 2005:43–9 High-Risk Asymptomatic Diabetic Patientsdentified as a variable for these analyses but subsequently
as included in post-hoc analyses. For all analyses, a p value
0.05 was considered statistically significant.
ESULTS
atient characteristics. Clinical variables are described in
able 1. The study population consisted predominantly of
iddle-age obese males with type 2 diabetes and a high
revalence of other risk factors. Median duration of diabetes
as 10 years. Prevalence of PAD was 31%. Indications for
tress testing were: 50% pre-surgical evaluation, 39% screen-
ng purposes, 3% vague non-chest symptoms such as fatigue
r abdominal pain, and 5% various miscellaneous indica-
ions such as arrhythmias or sildenafil use. In 3% of patients,
n indication could not be determined. Peripheral arterial
isease was present in 44% of patients referred for pre-
perative testing versus 19% of patients for a different
ndication.
CG and laboratory values. Pertinent laboratory studies
re summarized in Table 2. Median creatinine was 1.2
g/dl, with 29% of patients having creatinine 1.5 mg/dl.
ean total cholesterol was 209  53 mg/dl, low-density
ipoprotein (LDL) cholesterol 127  46 mg/dl, and high-
ensity lipoprotein cholesterol 44  15 mg/dl. Nearly
ne-fifth of patients were on a statin. Mean glycosylated
emoglobin was 9.1%  2.6%.
tress SPECT imaging results. An abnormal stress
PECT imaging scan was present in 826 patients (58%) and
high-risk scan in 261 patients (18%). Univariate analysis
evealed that 10 variables were significantly associated with
high-risk scan (Table 3). In the multivariate analysis,
CG Q waves demonstrated the strongest association
Table 4). The other six independent variables in the final
odel (chi-square  107, p  0.001) were PAD, glyco-
ylated hemoglobin, male gender, age, pharmacologic stress,
nd LDL cholesterol.
nalysis of patients with ECG Q waves or PAD. The
able 1. Clinical Characteristics for 1,427 Asymptomatic
iabetic Patients
Variable (n  1,427)
ean age (yrs) 60  14
ale gender 993 (70%)
ean body mass index 30  7
ype 2 diabetes 1,161 (81%)
ypertension 1,012 (71%)
yperlipidemia 741 (52%)
moking history 810 (57%)
amily history of premature CAD 376 (26%)
AD 443 (31%)
nsulin use 679 (48%)
ral diabetic agent 521 (37%)
ngiotensin-converting enzyme inhibitor 483 (35%)
tatin 264 (19%)
eta-blocker 217 (15%)
AD  coronary artery disease; PAD  peripheral arterial disease.31 patients with ECG Q waves had a significantly lower ERS than the rest of the population (51  7 vs. 54  4;
 0.001). Because Q waves were strongly associated with
high-risk scan, another multivariate model was con-
tructed excluding patients with Q waves. Four variables
ere found to be significantly associated with a high-risk
can: male gender, pharmacologic stress, PAD, and glyco-
ylated hemoglobin. This model (chi-square  69.4) was
eaker than the original model. The prevalence of PAD in
atients without a pre-operative indication was 19%. Pe-
ipheral arterial disease was significantly associated with a
igh-risk scan in this subset of patients (univariate chi-
quare  4.7, p  0.03).
nfluence of referral bias. Patients referred to tertiary care
enters are often “sicker” than community-based patients
17). Olmsted County, Minnesota, residents (community-
ased population, n  145) were compared to patients who
esided outside Olmsted County (referral population, n 
282). In referral patients, test indication was 51% pre-
urgical evaluation and 39% screening. These percentages
ere 41% and 46%, respectively, in the community cohort.
here were no differences between the community and
eferral populations in clinical characteristics (Table 5) or in
ercentages of patients with abnormal scans (65% vs. 57%,
 0.08) or high-risk scans (22% vs. 18%, p  0.22).
ubgroup analyses. Table 6 shows the yield of high-risk
cans in specific subsets of patients. The American Diabetes
ssociation guidelines recommend screening diabetic pa-
ients with an ECG indicative of ischemia or MI, evidence
f PAD, or two or more risk factors for CAD (4).
ompared to the entire study population, patients with an
bnormal resting ECG or with PAD were more likely to
ave a high-risk scan, but those with two or more risk
actors for CAD were not. The National Cholesterol
able 2. ECG and Laboratory Variables
Variable
CG Q waves 9%
CG ST-T wave abnormalities 34%
otal cholesterol (mg/dl)
200 54%
240 23%
DL cholesterol (mg/dl)
35 31%
DL cholesterol (mg/dl)
100 27%
100–129 32%
130–159 21%
160 20%
riglycerides (mg/dl)
150 54%
450 5%
lycosylated hemoglobin (%)
7.0 79%
9.0 45%
reatinine (mg/dl)
1.5 29%
CG  electrocardiogram; HDL  high-density lipoprotein; LDL  low-density
ipoprotein.ducation Program guidelines recommend treating hyper-
l
w
2
1
T
i
s
t

C
f
h
l
s
R
h
M
d
c
w
3
a
(
fi
P
(
w
i
p
n
o
w
f
D
T
C
and 2
46 Rajagopalan et al. JACC Vol. 45, No. 1, 2005
High-Risk Asymptomatic Diabetic Patients January 4, 2005:43–9ipidemia in diabetic patients as aggressively as in patients
ith established CAD (18). A high-risk scan was found in
0% of patients with LDL cholesterol 100 mg/dl, versus
4% of those with LDL cholesterol100 mg/dl (p 0.02).
est indication (pre-operative versus other) was not signif-
cantly associated with a high-risk scan (univariate chi-
quare  0.2, p  NS). In patients without pre-operative
est indication, Q waves, or PAD (a “less selected” subset, n
517), 15% still had a high-risk scan.
ardiac catheterization. Coronary angiography was per-
ormed within 6 months in 212 patients (Table 7). Among
igh-risk SPECT imaging patients, the majority (61%) had
eft main, three-vessel, and/or proximal left anterior de-
cending CAD, and only seven had no significant CAD.
elatively few low-risk SPECT imaging patients (16%) had
igh-risk angiographic CAD.
ortality analysis. By 10 years, 44% of the population had
ied. Survival curves according to SPECT imaging SSS risk
ategories are shown in Figure 1. Annual mortality rates
Table 3. Univariate Analysis of the Association
Scan
Variable Chi-Square
ECG Q waves 52.3
PAD 36.5
Age 25.3
Pharmacologic stress 21.5
ECG ST-T wave abnormality 18.0
Male gender 10.1
Glycosylated hemoglobin 8.1
Hypertension 6.7
Type 1 diabetes 6.6
Creatinine 5.2
Duration of diabetes 3.5
LDL cholesterol 2.9
HDL cholesterol 3.0
Triglycerides 2.8
Lipid-lowering medication 1.7
Smoking history 0.9
Body mass index 0.9
Hyperlipidemia 0.8
ACE inhibitor use 0.4
Insulin use 0.1
Oral diabetic agent use 0.1
Total:HDL cholesterol ratio 0.04
Beta-blocker use 0.01
Family history of CAD 0.002
Total cholesterol 0.0006
CI  confidence interval; other abbreviations as in Tables 1
Table 4. Variables Independently Associated W
Variable Chi-Square
ECG Q waves 38.3
PAD 13.9
Glycosylated hemoglobin 11.5
Male gender 9.2
Age 8.3
Pharmacologic stress 7.5
LDL cholesterol 5.1Abbreviations as in Tables 1 to 3.ere: high-risk 5.9%, intermediate-risk 5.0%, and low-risk
.6% (p  0.001 for differences between groups). Post-hoc
nalyses were performed to determine if a truly low-risk
annual mortality 1%) subset of patients could be identi-
ed. Annual mortality in patients without ECG Q waves or
AD and with a completely normal SPECT imaging scan
n  443) was lower but was still 2.9%. Annual mortality
as higher in patients with pre-operative versus other
ndication (5.9% vs. 2.7%, p  0.001). Annual mortality for
atients without pre-operative indication whose scan was
ormal (n  298) was 1.9%. For patients without pre-
perative indication, Q waves, or PAD, annual mortality
as 1.6% for those with a normal scan (n  237) and 3.4%
or those with a high-risk scan (n  79).
ISCUSSION
his study is the largest to date to analyze the prevalence of
AD by stress SPECT imaging in asymptomatic diabetic
tween 25 Clinical Variables and a High-Risk
Odds Ratio 95% CI p Value
4.02 2.76–5.87 0.001
2.34 1.77–3.08 0.001
1.03 1.02–1.04 0.001
1.92 1.46–2.52 0.001
1.81 1.37–2.37 0.001
1.67 1.22–2.27 0.002
1.08 1.02–1.13 0.004
0.69 0.52–0.92 0.01
0.60 0.41–0.89 0.01
0.92 0.85–0.99 0.02
1.01 1.00–1.02 NS
1.00 1.00–1.01 NS
0.99 0.98–1.00 NS
0.81 0.64–1.04 NS
0.79 0.55–1.13 NS
1.14 0.87–1.50 NS
1.01 0.99–1.03 NS
0.89 0.68–1.16 NS
1.10 0.83–1.46 NS
1.05 0.80–1.37 NS
0.95 0.72–1.26 NS
1.01 0.95–1.07 NS
0.98 0.67–1.43 NS
1.01 0.74–1.37 NS
1.00 0.99–1.00 NS
.
High-Risk Scan by Multivariate Analysis
Odds Ratio 95% CI p Value
3.92 2.54–6.04 0.001
1.90 1.36–2.67 0.001
1.11 1.05–1.18 0.001
1.79 1.23–2.63 0.002
1.02 1.01–1.04 0.004
1.63 1.15–2.32 0.006
1.00 1.00–1.01 0.02s Beith
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January 4, 2005:43–9 High-Risk Asymptomatic Diabetic Patientsatients. The yield of abnormal and high-risk scans was
onsiderable. A high-risk scan is an indication to proceed
ith coronary angiography (19). Sixty-one percent of pa-
ients with a high-risk scan who underwent coronary an-
iography had high-risk anatomy, consistent with other
tudies in broader patient populations (13,15,20). Patients
redicted to be at high risk by SPECT imaging did in fact
ave a high annual mortality rate of 5.9%. Patients predicted
o be at low risk did have a significantly lower but none-
heless substantial annual mortality of 3.6%. Patient selec-
ion bias appeared to influence these results. Post-hoc
nalysis identified a subset of patients (no pre-operative
ndication, no Q waves, no PAD) whose annual mortality
as 1.6% if their SPECT images were normal. Other
tudies have reported a higher-than-expected cardiac event
ate in diabetic patients with normal SPECT images (21).
hich patients to screen? A major goal of this study was
o identify which asymptomatic diabetic patients might
enefit most from screening. The most important variables
ere ECG Q waves and PAD. High-risk scans were
able 5. Patient Characteristics for Community-Based Population
n  145) and Referral-Based Population (n  1,282)
Variable
Community
Population
Referral
Population p Value
ge (yrs) 59  13 60  14 NS
ale gender 71% 69% NS
nsulin use 54% 47% NS
moking history 60% 56% NS
yperlipidemia 59% 51% NS
ypertension 76% 70% NS
amily history of CAD 28% 26% NS
AD 33% 31% NS
CG Q waves 8% 9% NS
CG ST-T wave
abnormalities
37% 34% NS
bbreviations as in Tables 1 and 2.
able 6. Yield of High-Risk Scans in Selected Patient
ubgroups
Subgroup
% of
Population
High-Risk
Scan  (%)
CG Q waves 9% 43%
bnormal ECG (Q waves and/or
ST-T wave abnormalities)
38% 26%
AD 31% 28%
wo or more CAD risk factors 77% 17%
DL cholesterol 100 mg/dl 73% 20%
ale, 65 yrs and abnormal ECG 40% 31%
re-operative indication 50% 18%
re-operative indication, PAD 22% 29%
o pre-operative indication 50% 19%
o PAD 69% 14%
o pre-operative indication,
no PAD
41% 17%
o pre-operative indication,
no Q waves
45% 17%
o pre-operative indication, no PAD,
no Q waves
37% 15%r
tbbreviations as in Tables 1 and 2.resent in 43% of patients with Q waves, in 26% with
waves and/or ST-T wave abnormalities, and in 28% with
AD. Previous studies have found a high prevalence of
AD in diabetic patients with PAD (11,22,23). These
ndings support the American Diabetic Association guide-
ines, which recommend that asymptomatic diabetic pa-
ients with ECG abnormalities or PAD should be consid-
red for screening (4).
omparison to prior studies. The exact prevalence of
ilent CAD in asymptomatic diabetic patients is difficult to
etermine. The largest population-based autopsy study of
49 diabetic patients without antemortem evidence of CAD
eported that approximately 50% of decedents 30 to 64 years
f age and 75% of decedents 65 years of age had
igh-grade coronary atherosclerosis (24). In a study using
lectron beam computed tomography, 48% had a calcium
core consistent with angiographically significant CAD
25). A wide range of abnormal stress myocardial perfusion
tudies between 4% and 57% has been reported (23,26–36).
irect comparison of these studies to our study is difficult
iven different selection criteria and other methodological
ifferences. The Detection of Ischemia in Asymptomatic
iabetics (DIAD) study is an ongoing prospective trial
esigned to examine this issue (37,38). The prevalence of
bnormal SPECT image was 16%, considerably lower than
n our study. Patients enrolled in the DIAD study versus
hose in our study likely represent different ends of the
pectrum of the asymptomatic diabetic population. Patients
elected for clinical trials are commonly “healthier” than the
igure 1. Survival curves for patients categorized by high-risk,
ntermediate-risk, and low-risk single-photon emission computed tomog-
able 7. Results of Coronary Angiography
SPECT Imaging
Risk Category
Left Main, 3-Vessel,
1- or 2-Vessel With
Proximal LAD
Other
1- or 2-
Vessel 0-Vessel
igh (n  127) 61% 34% 6%
ntermediate (n  60) 42% 35% 23%
ow (n  25) 16% 44% 40%
AD  left anterior descending; SPECT  single-photon emission computed
omography imaging.aphy imaging scans. The numbers at the bottom of the graph indicate
he number of patients at risk in each category at the given time point.
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High-Risk Asymptomatic Diabetic Patients January 4, 2005:43–9arger population of patients with the disease process (39).
onversely, our patients were referred for stress SPECT
maging for clinical reasons. By chart review, pre-operative
ssessment was the test indication in half of these patients.
symptomatic diabetic patients undergoing pre-operative
ssessment are likely to be at higher risk of CAD compared
o the general population of asymptomatic diabetic patients.
atients with ECG abnormalities suggestive of underlying
AD were excluded from the DIAD study. We included
hese patients in our study because an ECG is commonly
cquired as part of the screening process. ECG Q waves
ere a strong predictor of a high-risk scan. Patients with
waves also had a significantly lower SRS, a measure of the
xtent and severity of the perfusion defect on the resting
mages (i.e., myocardial scar).
tudy limitations. The major limitation is patient selection
ias, acknowledged above in the discussion of the DIAD
tudy. Clinicians may have been selecting the “sickest”
symptomatic diabetic patients for stress SPECT imaging.
nterestingly, there were no differences between the
ommunity-based and referral patients. Another limitation
elates to retrospective chart review for some data acquisi-
ion, which is often incomplete and not as accurate as
rospective collection. The study period spanned the years
986 to 2000. Conceivably, the prevalence of severe CAD
nd mortality rates could be lower at the present time
ecause of more widespread use of statins and angiotensin-
onverting enzyme inhibitors in diabetic patients. The
PECT images were interpreted by physicians who were
ware of the patients’ clinical data, which may have influ-
nced the SPECT reports. Assessment of left ventricular
unction was not performed in a uniform manner and
herefore was not included as part of this study. It is possible
hat some patients with normal SPECT images may have
ad left ventricular dysfunction, contributing to their
igher-than-expected mortality rate.
ONCLUSIONS
ur study cannot definitively address the role of stress
PECT imaging for screening all asymptomatic diabetic
atients. The percentage of abnormal scans was higher than
n most other studies (23,26–38). Patients with high-risk
cans did in fact have a high annual mortality rate approach-
ng 6%. Advantages of our study include the large study
opulation and the use of stress SPECT imaging in a broad
linical practice, including performing the test in many
atients as part of pre-operative assessment (a “real-world”
ractice). The results suggest a role for screening stress
PECT imaging in selected asymptomatic diabetic patients,
specially those with ECG abnormalities or evidence of
AD. Although no randomized trial has proven that
symptomatic diabetic patients with severe CAD have an
mprovement in survival if treated with revascularization,
ypass surgery is the treatment of choice for asymptomatic
atients with severe CAD according to the Americanollege of Cardiology/American Heart Association guide-
ines on the basis of expert consensus (19). The findings
rom our study will need to be interpreted in conjunction
ith the results of the ongoing DIAD study to formulate
ore definitive recommendations concerning screening
tress SPECT imaging in asymptomatic diabetic patients.
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